Page 2 - Anixa Biosciences Daily News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Anixa Biosciences (NASDAQ:ANIX) Stock Rating Reaffirmed by HC Wainwright

HC Wainwright reaffirmed their buy rating on shares of Anixa Biosciences (NASDAQ:ANIX – Free Report) in a research report sent to investors on Tuesday morning, Benzinga reports. HC Wainwright currently has a $12.00 price objective on the stock. HC Wainwright also issued estimates for Anixa Biosciences’ FY2025 earnings at ($0.40) EPS. Anixa Biosciences Price Performance […]

Anixa biosciencesUs bancorpAnixa biosciences company profileVirtu financialAnixa biosciences incTower research capitalFree reportAnixa bioscienceGet free reportWealth managementResearch capitalAnixa biosciences dailyNasdaq anixReiterated ratingHc wainwright

Anixa Biosciences, Inc (NASDAQ:ANIX) Short Interest Up 10 7% in January

Anixa Biosciences, Inc (NASDAQ:ANIX) Short Interest Up 10 7% in January
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Anixa biosciencesVirtu financialConcorde asset managementUs bancorpTower research capitalAnixa biosciences incGet free reportWealth managementAsset managementResearch capitalAnixa biosciences daily

HC Wainwright Reiterates Buy Rating for Anixa Biosciences (NASDAQ:ANIX)

HC Wainwright reissued their buy rating on shares of Anixa Biosciences (NASDAQ:ANIX – Free Report) in a report issued on Thursday morning, Benzinga reports. The brokerage currently has a $12.00 target price on the stock. Anixa Biosciences Price Performance Shares of Anixa Biosciences stock opened at $4.08 on Thursday. Anixa Biosciences has a fifty-two week […]

Anixa biosciencesConcorde asset managementUs bancorpWestside investment management incAnixa biosciences company profileVirtu financialAnixa biosciences incFree reportInvestment managementWealth managementGet free reportAnixa biosciences dailyNasdaq anixReiterated ratingHc wainwright

Anixa Biosciences, Inc to Post FY2023 Earnings of ($0 32) Per Share, HC Wainwright Forecasts (NASDAQ:ANIX)

Anixa Biosciences, Inc to Post FY2023 Earnings of ($0 32) Per Share, HC Wainwright Forecasts (NASDAQ:ANIX)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Anixa bioscienceAmit kumarAnixa biosciencesInternational assets investment managementAnixa biosciences company profileAnixa biosciences incWestside investment management incUs bancorpConcorde asset managementVirtu financialFree reportInvestment managementAsset managementAssets investment managementGet free reportAnixa biosciences daily

Anixa Biosciences (NASDAQ:ANIX) Given Buy Rating at HC Wainwright

HC Wainwright reissued their buy rating on shares of Anixa Biosciences (NASDAQ:ANIX – Free Report) in a research note released on Tuesday, Benzinga reports. They currently have a $12.00 target price on the stock. Separately, TheStreet lowered Anixa Biosciences from a c- rating to a d rating in a research note on Friday, June 16th. […]

Anixa biosciencesAmit kumarInternational assets investment managementAnixa biosciences incUs bancorpVirtu financialWestside investment management incNations financial group incFree reportGet free reportFinancial groupInvestment managementAssets investment managementAnixa biosciences dailyNasdaq anixReiterated rating